Methyl Alcohol

Methyl Alcohol

SCHEMBL929693

CO.OCc1ccccc1OCCCN1CCC(c2noc3cc(F)ccc23)CC1

nearest known ligand 0.77

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 2/20 0.65
CHRM1 P11229 2/20 0.65
DRD4 P21917 2/20 0.65
DRD3 P35462 2/20 0.65
SIGMAR1 Q99720 2/20 0.65
CHRM4 P08173 1/20 0.65
CHRM5 P08912 1/20 0.65
CHRM3 P20309 1/20 0.65
ABCB11 O95342 1/20 0.65
HTR1A P08908 1/20 0.65
ADRA2A P08913 1/20 0.65
DRD2 P14416 1/20 0.65
ADRA2B P18089 1/20 0.65
ADRA2C P18825 1/20 0.65
DRD1 P21728 1/20 0.65
ACHE P22303 1/20 0.65
SLC6A2 P23975 1/20 0.65
HTR2A P28223 1/20 0.65
HTR2C P28335 1/20 0.65
SLC6A4 P31645 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methyl Alcohol SCHEMBL718326 0.89 DRD2 (0.69) CHRM2CHRM1DRD4DRD3SIGMAR1
Methyl Alcohol SCHEMBL718327 0.88 HTR1A (0.76) CHRM2CHRM1DRD4DRD3SIGMAR1
Alcohol SCHEMBL142048 0.88 DRD2 (0.66) CHRM2CHRM1DRD4DRD3SIGMAR1
Methyl Alcohol SCHEMBL142049 0.88 ABCB11 (0.66) CHRM2CHRM1DRD4DRD3SIGMAR1
Methane SCHEMBL7348385 0.86 HTR1A (0.65) CHRM2CHRM1DRD4DRD3SIGMAR1
SCHEMBL7948167 0.86 KCNH2 (0.64) CHRM2CHRM1DRD4DRD3SIGMAR1
SCHEMBL5995122 0.86 HTR1A (0.67) HTR1ADRD2HTR2A
SCHEMBL930760 0.85 ABCB11 (0.63) CHRM2CHRM1DRD4DRD3SIGMAR1
SCHEMBL21587534 0.85 HTR1A (0.67) CHRM2CHRM1DRD4DRD3SIGMAR1
Hydrochloric Acid SCHEMBL1545933 0.85 HTR1A (0.66) HTR1ADRD2HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2152917-B1 GENETIC MARKERS FOR EFFICACY OF ILOPERIDONE IN THE TREATMENT OF PSYCHOTIC SYMPTOMS VANDA PHARMACEUTICALS INC (US) 2016-03-23 EP disclosed
US-9080214-B2 Genetic markers for efficacy of iloperidone in the treatment of psychotic symptoms VANDA PHARMACEUTICALS, INC. (US) 2015-07-14 US disclosed
US-20110021566-A1 GENETIC MARKERS FOR EFFICACY OF ILOPERIDONE IN THE TREATMENT OF PSYCHOTIC SYMPTOMS VANDA PHARMACEUTICALS, INC. 2011-01-27 US disclosed
EP-2152917-A2 GENETIC MARKERS FOR EFFICACY OF ILOPERIDONE IN THE TREATMENT OF PSYCHOTIC SYMPTOMS Vanda Pharmaceuticals Inc. (US) 2010-02-17 EP disclosed
WO-2008144599-A2 GENETIC MARKERS FOR EFFICACY OF ILOPERIDONE IN THE TREATMENT OF PSYCHOTIC SYMPTOMS VANDA PHARMACEUTICALS INC. (US) 2008-11-27 WO disclosed